Amisulpride: Clinical Trials

9 trials of Amisulpride, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 unknown. 9 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 19Completed 8, Unknown 1

Follow Amisulpride: new trials by email Literature Review of Amisulpride trials Research Report on Amisulpride

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body
Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd. - Bioequivalence, Schizophrenia
Phase 1UnknownThe Affiliated Hospital of Qingdao University1002023-09-202023-10-04
Effects of a Single Dose of Amisulpride on Functional Brain Changes
Amisulpride Pill, Placebo - Major Depressive Disorder
Phase 1CompletedSimone Grimm1272022-05-172023-11-24
PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment
Amisulpride IV, Amisulpride Oral Tablet - Renal Disease, End Stage
Phase 1CompletedAcacia Pharma Ltd122021-06-032021-12-13
Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics
SEP-363856, Amisulpride, Placebo - Schizophrenia
Phase 1CompletedOtsuka Pharmaceutical Development & Commercialization, Inc.1052014-03-012024-06-26
Thorough QT Study of Intravenous Amisulpride
APD421 5 mg, APD421 40 mg, Moxifloxacin - Healthy
Phase 1CompletedAcacia Pharma Ltd402013-11-012018-11-29
An Investigation of Early Life Stress and Depression
Amisulpride, Placebo - Major Depressive Disorder (MDD), History of Childhood Sexual Abuse (CSA)
Phase 1CompletedMclean Hospital1532013-08-012025-05-07
Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study
Cannabidiol CR, Cannabidiol, Amisulpride - Schizophrenia
Phase 1CompletedCentral Institute of Mental Health, Mannheim742013-01-012018-03-08
The Effects of Dopamine on Reward Processing
amisulpride, placebo - Major Depressive Disorder (MDD)
Phase 1CompletedMclean Hospital1592012-02-012018-04-27
Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors
Pramipexole, Amisulpride - Obsessive-Compulsive Disorder
Phase 1CompletedGlaxoSmithKline522006-08-012014-09-15

Conditions studied

Depressive Disorder, Major (3)  ·  Schizophrenia (3)  ·  Depression (1)  ·  Kidney Failure, Chronic (1)  ·  Obsessive-Compulsive Disorder (1)

Sponsors

Acacia Pharma Ltd (2)  ·  Mclean Hospital (2)  ·  Central Institute of Mental Health, Mannheim (1)  ·  GlaxoSmithKline (1)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (1)  ·  Simone Grimm (1)  ·  The Affiliated Hospital of Qingdao University (1)

Countries

United States (3)  ·  Germany (2)  ·  United Kingdom (2)  ·  China (1)

Top investigators

Christian Keicher, Dr. med. (1)  ·  Diego A Pizzagalli, PhD (1)  ·  Diego Pizzagalli, PhD (1)  ·  Gabriel Fox, MB BChir (1)  ·  Gabriel Fox, MD (1)

Results publications

PMID 31784354, PMID 28942738, PMID 37550314, PMID 38012795

NIH funding

2008 (1), R01MH068376 (1), R01MH095809 (1)